BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene

被引:70
作者
Kennedy, RD
Gorski, JJ
Quinn, JE
Stewart, GE
James, CR
Moore, S
Mulligan, K
Emberley, ED
Lioe, TF
Morrison, PJ
Mullan, PB
Reid, G
Johnston, PG
Watson, PH
Harkin, DP
机构
[1] Queens Univ Belfast, Ctr Canc Res, Belfast BT9 7AB, Antrim, North Ireland
[2] Belfast City Hosp, Dept Pathol, Belfast BT9 7AD, Antrim, North Ireland
[3] Belfast City Hosp, Dept Med Genet, Belfast BT9 7AD, Antrim, North Ireland
[4] Univ Manitoba, Fac Med, Dept Pathol, Winnipeg, MB, Canada
[5] Arradx Ltd, Craigavon, North Ireland
[6] European Mol Biol Lab, Heidelberg, Germany
关键词
D O I
10.1158/0008-5472.CAN-05-1841
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Evidence is accumulating to suggest that some of the diverse functions associated with BRCA1 may relate to its ability to transcriptionally regulate key downstream target genes. Here, we identify, S100A7 (psoriasin), S100A8, and S100A9, members of the S100A family of calcium-binding proteins, as novel BRCA1-repressed targets. We show that functional BRCA1 is required for repression of these family members and that a BRCA1 disease-associated mutation abrogates BRCA1-mediated repression of psoriasin. Furthermore, we show that BRCA1 and c-Myc form a complex on the psoriasin promoter and that BRCA1-mediated repression of psoriasin is dependent on functional c-Myc. Finally, we show that psoriasin expression is induced by the topoisomerase II alpha poison, etoposide, in the absence of functional BRCA1 and increased psoriasin expression enhances cellular sensitivity to this chemotherapeutic agent. Therefore, we identified a novel transcriptional mechanism that is likely to contribute to BRCA1-mediated resistance to etoposide.
引用
收藏
页码:10265 / 10272
页数:8
相关论文
共 36 条
[1]   BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase a [J].
Anderson, SE ;
Schlegel, BP ;
Nakajima, T ;
Wolpin, ES ;
Parvin, JD .
NATURE GENETICS, 1998, 19 (03) :254-256
[2]   BRCA1 regulates the interferon γ-mediated apoptotic response [J].
Andrews, HN ;
Mullan, PB ;
McWilliams, S ;
Sebelova, S ;
Quinn, JE ;
Gilmore, PM ;
McCabe, N ;
Pace, A ;
Koller, B ;
Johnston, PG ;
Haber, DA ;
Harkin, DP .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (29) :26225-26232
[3]   Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line [J].
Annab, LA ;
Hawkins, RE ;
Solomon, G ;
Barrett, JC ;
Afshari, CA .
BREAST CANCER RESEARCH, 2000, 2 (02) :139-148
[4]   BRCA1 is associated with a human SWI/SNF-related complex: Linking chromatin remodeling to breast cancer [J].
Bochar, DA ;
Wang, L ;
Beniya, H ;
Kinev, A ;
Xue, YT ;
Lane, WS ;
Wang, WD ;
Kashanchi, F ;
Shiekhattar, R .
CELL, 2000, 102 (02) :257-265
[5]   IDENTIFICATION OF A GROUP OF PROTEINS THAT ARE STRONGLY UP-REGULATED IN TOTAL EPIDERMAL-KERATINOCYTES FROM PSORIATIC SKIN [J].
CELIS, JE ;
CRUGER, D ;
KIIL, J ;
LAURIDSEN, JB ;
RATZ, G ;
BASSE, B ;
CELIS, A .
FEBS LETTERS, 1990, 262 (02) :159-164
[6]   Autoubiquitination of the BRCA1-BARD1 RING ubiquitin ligase [J].
Chen, A ;
Kleiman, FE ;
Manley, JL ;
Ouchi, T ;
Pan, ZQ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (24) :22085-22092
[7]  
Chiarle R, 2001, BREAST CANCER RES, V3, P91
[8]   S100A7 (psoriasin) expression is associated with aggressive features and alteration of Jab1 in ductal carcinoma in situ of the breast [J].
Emberley, ED ;
Alowami, S ;
Snell, L ;
Murphy, LC ;
Watson, PH .
BREAST CANCER RESEARCH, 2004, 6 (04) :R308-R315
[9]  
Emberley ED, 2003, CLIN CANCER RES, V9, P2627
[10]  
Emberley ED, 2003, CANCER RES, V63, P1954